C1qA ELISA kit
- Known as:
- C1qA Enzyme-linked immunosorbent assay test reagent
- Catalog number:
- DL-C1qA-Hu
- Product Quantity:
- 96T
- Category:
- Elisa Kits
- Supplier:
- WDSTD
- Gene target:
- C1qA ELISA kit
Related genes to: C1qA ELISA kit
- Gene:
- C1QA NIH gene
- Name:
- complement C1q A chain
- Previous symbol:
- -
- Synonyms:
- -
- Chromosome:
- 1p36.12
- Locus Type:
- gene with protein product
- Date approved:
- 2001-06-22
- Date modifiied:
- 2019-04-23
Related products to: C1qA ELISA kit
Human ELC ELISA KIT 96 TEST
OxiSelect In Vitro ROS/RNS Assay Kit (Green Fluorescence), Trial Size
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect Methylglyoxal (MG) Competitive ELISA Kit
OxiSelect TBARS Assay Kit (MDA Quantitation), Trial Size
OxiSelect Total Antioxidant Capacity (TAC) Assay Kit, Trial Size
OxiSelect™ In Vitro ROS RNS Assay Kit (Green Fluorescence), Trial Size(1-3)-beta-D-glucan Sandwich ELISA, Double Antibody(1-Kit )11,12-EET DHET Immunoassay Kit(1-Kit )11,12-EET_DHET Immunoassay Kit(1-Kit) 11,12-DHET Immunoassay Kit(1-Kit) 14,15-DHET Human Urine ELISA Kit(1-Kit) 14,15-DHET Hypertension ELISA Kit(1-Kit) 14,15-DHET sEH activity ELISA Kit(1-Kit) 14,15-EET DHET Hypertension ELISA Kit Related articles to: C1qA ELISA kit
- Glioma represents the most prevalent and lethal primary malignant tumor of the central nervous system, characterized by remarkable cellular heterogeneity and poor prognosis. Comprehensive characterization of glioma at single-cell resolution is essential for identifying novel therapeutic targets and improving patient outcomes. - Source: PubMed
Publication date: 2026/05/28
Gu ChengcongWu XiaojinYang Liang - Chronic Chagas cardiomyopathy (CCC) remains a major cause of heart failure (HF)-related mortality in Latin America and is increasingly recognized as a global health concern. Prognostic models developed in non-Chagas populations often perform poorly in CCC, highlighting the need for etiology-specific risk stratification. - Source: PubMed
Publication date: 2026/06/08
Patané José S LGiugni Fernando RRosa Rogério SMarcondes-Braga Fabiana GMansur Alfredo JPereira Alexandre CKrieger Jose E - To investigate the genetic basis of early-onset systemic lupus erythematosus (EOSLE) in a large Indian pediatric SLE (pSLE) cohort. - Source: PubMed
Sharma MadhubalaPilania Rakesh KumarVolpi StefanoBocca PaolaJindal AnkurVignesh PandiarajanSuri DeeptiSharma SaniyaDhaliwal ManpreetGarg RavinderKaur GurjitSaka RuchiMamadpur MahabaleshwarMahadevan SabarinathHaque IsrarulGhosh ParasarReddy MounikaChoudhary AbhijitArora AmitDas ReenaAhluwalia JasminaGattorno MarcoSingh SurjitRawat Amit - Diabetic nephropathy (DN) poses a growing worldwide health challenge as a leading cause of end-stage renal disease, a condition that arises from a complex, poorly defined pathophysiology. Endoplasmic reticulum stress (ERS) is recognized as a pivotal contributor to renal cell injury in DN. While complement component C1q A chain (C1QA) is integral to innate immunity, its specific role and mechanism in DN, particularly in relation to ERS, remain unexplored. - Source: PubMed
Publication date: 2026/06/03
Zhang XiaoyingLi LeiZhang FengjiaoZhu MengluKang ZhiqiangMao Yu - Small extracellular vesicles (sEVs) derived from mesenchymal stem cells represent a novel regenerative therapeutic strategy for various liver injuries. Menstrual blood-derived mesenchymal stem cells (MenSCs)-derived EVs may have therapeutic potential in treating liver fibrosis. In this study, systemically injected MenSCs-derived sEVs migrated into the injured liver, ameliorated serological indices, and decreased collagenous fiber accumulation in carbon tetrachloride (CCl)-induced liver fibrosis mouse models. We aimed to explore the underlying mechanism for the therapeutic effect of MenSC-sEVs. - Source: PubMed
Publication date: 2026/05/28
Chen LijunZhang NingHuang YuqiQu JingjingFang YangxinYuan YinFu JiaminWan DalongZhang QiChen LuWen ZuoshiChen XinYuan LiXu ZhenyuLi YifeiHu ChenxiaYan HuadongIzawa HiromiYoshimoto TakayukiLi LanjuanXiang Charlie